B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME). Their anti-tumor functions include recognizing tumor-associated antigens, ...

Researchers in Madrid have developed an in vitro stimulation model showing that B cells from patients with common variable ...

Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives innovations ...

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...

B cells are white blood cells that form a core part of the body's adaptive immune system, enabling it to recognize specific infections, remember them, and mount a targeted response by producing ...

Single-cell transcriptomics across multiple COVID-19 cohorts reveals that peripheral B cell dysregulation, marked by plasmablast expansion and naive B cell depletion, is associated with post-COVID ...

B cells have enormous potential in the field of immunotherapy. By engineering B cells to express specific antibodies, researchers can use them as an alternative to vaccines for infectious diseases and ...

However, details of the intervening steps, as researchers have learned in the past 65 years, are quite complex — certain cells carry the flu antigen to the immune system, specific immune cells respond ...

T cells are not the only attackersWhen people hear about immunotherapy for blood cancers, many may think of CAR-T cell ...